banner

Linagliptin

Linagliptin

Synonym

8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione

CAS #

668270-12-0

Molecular Formula

C25H28N8O2

Molecular Weight

472.54

Structure

CAS 668270-12-0

Product Introduction

Linagliptin ( trade names Tradjenta and Trajenta,cas 668270-12-0) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes.Linagliptin (cas 668270-12-0) was approved by the U.S. Food and Drug Administration (FDA) on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly.